Mark Gustafson - 14 Dec 2021 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
/s/ Mark Gustafson
Issuer symbol
ALZN
Transactions as of
14 Dec 2021
Net transactions value
-$57,086
Form type
4
Filing time
16 Dec 2021, 16:00:17 UTC
Previous filing
18 Oct 2021
Next filing
16 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Sale $57,086 -20,000 -40% $2.85 30,000 14 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.8543. The range of sale prices on the transaction date was $2.85 to $2.87 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price